Prostate Cancer - Results from #20840

Recent advances in treatment of patients with castration-resistant prostate cancer after docetaxel failure - Abstract April 11, 2014

Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL - Abstract April 11, 2014

Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: Phase I/II randomized placebo-controlled trial - Abstract April 11, 2014

4D ultrasound speckle tracking of intra-fraction prostate motion: A phantom-based comparison with x-ray fiducial tracking using CyberKnife - Abstract April 11, 2014

Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer - Abstract April 11, 2014

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer - Abstract April 11, 2014

Sipuleucel-T and immunotherapy in the treatment of prostate cancer - Abstract April 11, 2014

Placement of empty catheters for an HDR-Emulating LDR Prostate Brachytherapy technique: Comparison to standard intraoperative planning - Abstract April 11, 2014

Defining prostate cancer risk after radical prostatectomy - Abstract April 11, 2014

Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: Does the anaesthetic technique matter? - Abstract April 11, 2014

Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer - Abstract April 11, 2014

A risk-adjusted definition of biochemical recurrence after radical prostatectomy - Abstract April 11, 2014

A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer-the UK NCRN Pomi-T study - Abstract April 11, 2014

Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC) - Abstract April 11, 2014

Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy - Abstract April 11, 2014

Castration-resistant prostate cancer (CRPC) - Abstract April 11, 2014

Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy - Abstract April 11, 2014

Radium-223 dichloride: A review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases - Abstract April 10, 2014

Retzius-sparing Robot-assisted Laparoscopic Radical Prostatectomy - combining the best of retropubic and perineal approache - Abstract April 9, 2014

The impact of the androgen deprivation therapy on the risk of coronary heart disease in patients with non-metastatic prostate cancer: A population-based study - Abstract April 9, 2014

Page 1043 of 1437